Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 3
1990 11
1991 20
1992 27
1993 53
1994 78
1995 89
1996 98
1997 104
1998 124
1999 123
2000 106
2001 124
2002 125
2003 138
2004 144
2005 133
2006 132
2007 120
2008 119
2009 128
2010 143
2011 130
2012 130
2013 149
2014 146
2015 137
2016 143
2017 147
2018 171
2019 148
2020 155
2021 142
2022 135
2023 139
2024 162
2025 212
2026 175

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,144 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK, Talukder M, Williams G. Gupta AK, et al. J Dermatolog Treat. 2022 Nov;33(7):2946-2962. doi: 10.1080/09546634.2022.2109567. Epub 2022 Aug 15. J Dermatolog Treat. 2022. PMID: 35920739 Free article. Review.
EFFICACY AND SAFETY: A probable efficacy ranking, in decreasing order, is - dutasteride 0.5 mg/d, finasteride 5 mg/d, minoxidil 5 mg/d, finasteride 1 mg/d, followed by minoxidil 0.25 mg/d. ...Thus, dutasteride suppresses DHT levels more than finasteride in th …
EFFICACY AND SAFETY: A probable efficacy ranking, in decreasing order, is - dutasteride 0.5 mg/d, finasteride 5 mg/d, minoxidil 5 mg/ …
Finasteride for hair loss: a review.
Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Gupta AK, et al. J Dermatolog Treat. 2022 Jun;33(4):1938-1946. doi: 10.1080/09546634.2021.1959506. Epub 2021 Aug 2. J Dermatolog Treat. 2022. PMID: 34291720 Free article. Review.
METHODS: The literature is comprehensively summarized on the pharmacodynamics, pharmacokinetics, mechanism of action, and metabolism of finasteride. Pairwise and network meta-analyses were performed to assess the efficacy of finasteride reported in clinical trials. …
METHODS: The literature is comprehensively summarized on the pharmacodynamics, pharmacokinetics, mechanism of action, and metabolism of f …
Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial.
Piraccini BM, Blume-Peytavi U, Scarci F, Jansat JM, Falqués M, Otero R, Tamarit ML, Galván J, Tebbs V, Massana E; Topical Finasteride Study Group. Piraccini BM, et al. J Eur Acad Dermatol Venereol. 2022 Feb;36(2):286-294. doi: 10.1111/jdv.17738. Epub 2021 Oct 25. J Eur Acad Dermatol Venereol. 2022. PMID: 34634163 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate the efficacy and safety of topical finasteride compared with placebo, and to analyse systemic exposure and overall benefit compared with oral finasteride. ...Incidence and type of adverse events, and cause of discontinuation, did not differ m …
OBJECTIVES: To evaluate the efficacy and safety of topical finasteride compared with placebo, and to analyse systemic exposure and ov …
Risk of Depression Associated With Finasteride Treatment.
Pompili M, Magistri C, Maddalena S, Mellini C, Persechino S, Baldessarini RJ. Pompili M, et al. J Clin Psychopharmacol. 2021 May-Jun 01;41(3):304-309. doi: 10.1097/JCP.0000000000001379. J Clin Psychopharmacol. 2021. PMID: 33814544
METHODS: We carried out a systematic review of reports pertaining to association of finasteride treatment with clinical depression or other adverse psychiatric effects. We analyzed reported risks of depression by pooling of rates and by meta-analysis of comparisons of subj …
METHODS: We carried out a systematic review of reports pertaining to association of finasteride treatment with clinical depression or …
Sexual side effects of 5-alpha-reductase inhibitors finasteride and dutasteride: A comprehensive review.
Fertig RM, Gamret AC, Darwin E, Gaudi S. Fertig RM, et al. Dermatol Online J. 2017 Nov 11;23(11):13030/qt24k8q743. Dermatol Online J. 2017. PMID: 29447628 Free article. Review.
The 5-alpha-reductase inhibitors finasteride and dutasteride are frequently used in the treatment of androgenetic alopecia and benign prostatichyperplasia. ...This review is an extensive look at the sexual effects of 5-alpha-reductase inhibitors and compares outcomes for …
The 5-alpha-reductase inhibitors finasteride and dutasteride are frequently used in the treatment of androgenetic alopecia and benign …
Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review.
Gupta AK, Talukder M. Gupta AK, et al. Expert Opin Pharmacother. 2025 Mar;26(4):367-379. doi: 10.1080/14656566.2025.2461169. Epub 2025 Feb 3. Expert Opin Pharmacother. 2025. PMID: 39880789 Review.
The systemic treatments of AGA include 5-alpha reductase inhibitors (finasteride, dutasteride) and low-dose oral minoxidil. AREAS COVERED: The article comprehensively reviews dutasteride's pharmacokinetics, pharmacodynamics, clinical efficacy, and side effects to support c …
The systemic treatments of AGA include 5-alpha reductase inhibitors (finasteride, dutasteride) and low-dose oral minoxidil. AREAS COV …
Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. Kaufman KD, et al. J Am Acad Dermatol. 1998 Oct;39(4 Pt 1):578-89. doi: 10.1016/s0190-9622(98)70007-6. J Am Acad Dermatol. 1998. PMID: 9777765 Clinical Trial.
OBJECTIVE: Our purpose was to determine whether finasteride treatment leads to clinical improvement in men with male pattern hair loss. METHODS: In two 1-year trials, 1553 men (18 to 41 years of age) with male pattern hair loss received oral finasteride 1 mg/d or pl …
OBJECTIVE: Our purpose was to determine whether finasteride treatment leads to clinical improvement in men with male pattern hair los …
Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
Gupta AK, Talukder M. Gupta AK, et al. J Cosmet Dermatol. 2022 May;21(5):1841-1848. doi: 10.1111/jocd.14895. Epub 2022 Mar 14. J Cosmet Dermatol. 2022. PMID: 35238144 Review.
BACKGROUND: Oral finasteride is an FDA-approved treatment for androgenetic alopecia (AGA). Topical finasteride, while not FDA-approved, lacks the systemic adverse effects associated with oral finasteride. ...Moreover, a combination of topical minoxidil and to …
BACKGROUND: Oral finasteride is an FDA-approved treatment for androgenetic alopecia (AGA). Topical finasteride, while not FDA- …
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J. Drake L, et al. J Am Acad Dermatol. 1999 Oct;41(4):550-4. J Am Acad Dermatol. 1999. PMID: 10495374 Clinical Trial.
OBJECTIVE: We attempted to determine the effect of finasteride on scalp skin and serum androgens. METHODS: Men with androgenetic alopecia (N = 249) underwent scalp biopsies before and after receiving 0.01, 0.05, 0.2, 1, or 5 mg daily of finasteride or placebo for 42 …
OBJECTIVE: We attempted to determine the effect of finasteride on scalp skin and serum androgens. METHODS: Men with androgenetic alop …
Finasteride.
Chaudhary UB, Turner JS. Chaudhary UB, et al. Expert Opin Drug Metab Toxicol. 2010 Jul;6(7):873-81. doi: 10.1517/17425255.2010.495944. Expert Opin Drug Metab Toxicol. 2010. PMID: 20536414 Review.
AREAS COVERED IN THIS REVIEW: This review outlines a detailed background on the development of finasteride as a chemopreventive agent for prostate cancer. It discusses the Prostate Cancer Prevention Trial, a large randomized clinical trial that showed reduction in prostate …
AREAS COVERED IN THIS REVIEW: This review outlines a detailed background on the development of finasteride as a chemopreventive agent …
4,144 results